Literature DB >> 16024767

Impact of metabolism on the safety of estrogen therapy.

Katalin Prokai-Tatrai1, Laszlo Prokai.   

Abstract

Estrogen metabolism has received attention owing to the recognition that oxidative metabolism of these hormones could play a very important role in the initiation and evolution of estrogen-related cancerous processes. This review discusses principal metabolic pathways associated with the molecular constituents found in common hormone formulations. The focus is the formation of catechol estrogens that then oxidize to redox-active and electrophilic quinones, along with potential mechanisms by which these metabolites contribute to oxidative stress and induce damage to essential biological macromolecules. Recent investigations involving specific estrogen metabolites that may offer potential increase of therapeutic safety for estrogen therapy in the future have also been highlighted.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16024767     DOI: 10.1196/annals.1347.018

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  11 in total

Review 1.  The effects of ethinylestradiol and progestins ("the pill") on cognitive function in pre-menopausal women.

Authors:  Andrea Gogos; YeeWen Candace Wu; Amy S Williams; Linda K Byrne
Journal:  Neurochem Res       Date:  2014-09-30       Impact factor: 3.996

2.  Quinone Methide Bioactivation Pathway: Contribution to Toxicity and/or Cytoprotection?

Authors:  Judy L Bolton
Journal:  Curr Org Chem       Date:  2014-01-01       Impact factor: 2.180

3.  Continuous estrone treatment impairs spatial memory and does not impact number of basal forebrain cholinergic neurons in the surgically menopausal middle-aged rat.

Authors:  Elizabeth B Engler-Chiurazzi; Joshua S Talboom; B Blair Braden; Candy W S Tsang; Sarah Mennenga; Madeline Andrews; Laurence M Demers; Heather A Bimonte-Nelson
Journal:  Horm Behav       Date:  2012-04-13       Impact factor: 3.587

4.  Understanding the cognitive impact of the contraceptive estrogen Ethinyl Estradiol: tonic and cyclic administration impairs memory, and performance correlates with basal forebrain cholinergic system integrity.

Authors:  Sarah E Mennenga; Julia E Gerson; Stephanie V Koebele; Melissa L Kingston; Candy W S Tsang; Elizabeth B Engler-Chiurazzi; Leslie C Baxter; Heather A Bimonte-Nelson
Journal:  Psychoneuroendocrinology       Date:  2015-01-12       Impact factor: 4.905

5.  Non-Feminizing Estrogens Do Not Exhibit Antidepressant-like Activity.

Authors:  Katalin Prokai-Tatrai; Vien Nguyen; Laszlo Prokai
Journal:  J Pharm Drug Res       Date:  2016-05-15

6.  Mechanistic investigations on the antioxidant action of a neuroprotective estrogen derivative.

Authors:  Katalin Prokai-Tatrai; Pal Perjesi; Nilka M Rivera-Portalatin; James W Simpkins; Laszlo Prokai
Journal:  Steroids       Date:  2007-11-04       Impact factor: 2.668

7.  Progesterone regulates catechol-O-methyl transferase gene expression in breast cancer cells: distinct effect of progesterone receptor isoforms.

Authors:  Salama A Salama; Mohammad Jamaluddin; Raj Kumar; Memy H Hassan; Ayman Al-Hendy
Journal:  J Steroid Biochem Mol Biol       Date:  2007-06-30       Impact factor: 4.292

Review 8.  Potential mechanisms of estrogen quinone carcinogenesis.

Authors:  Judy L Bolton; Gregory R J Thatcher
Journal:  Chem Res Toxicol       Date:  2007-12-04       Impact factor: 3.739

9.  Echinacoside Protects against 6-Hydroxydopamine-Induced Mitochondrial Dysfunction and Inflammatory Responses in PC12 Cells via Reducing ROS Production.

Authors:  Yue-Hua Wang; Zhao-Hong Xuan; Shuo Tian; Guan-Hua Du
Journal:  Evid Based Complement Alternat Med       Date:  2015-02-18       Impact factor: 2.629

10.  Prospective, randomized, double-blind, placebo-controlled phase IIa clinical trial on the effects of an estrogen-progestin combination as add-on to inpatient psychotherapy in adult female patients suffering from anorexia nervosa.

Authors:  Georgios Paslakis; Stefanie Maas; Bernd Gebhardt; Andreas Mayr; Manfred Rauh; Yesim Erim
Journal:  BMC Psychiatry       Date:  2018-04-10       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.